OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
OpenAI researcher Miles Wang is reportedly leaving to start an AI drug discovery startup, in talks to raise about $200 million at a $2 billion valuation, with Lightspeed in discussions to lead. The talks highlight investor interest in applying AI to life sciences.
